Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Progress in Sugen's cancer development pipeline

Jan. 9, 1997

OXiGENE and Boston Medical Center announce collaboration

Jan. 9, 1997

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

BCH-4556 slated to enter clinical testing

Jan. 8, 1997

Pharmacyclics completes phase I testing of Lu-Tex

Jan. 8, 1997

Draxis acquires Canadian rights to Mylan's paclitaxel formulation

Jan. 8, 1997

New form of DNA linked to prostate cancer

Jan. 8, 1997

Joint venture formed to develop cancer therapy

Jan. 7, 1997

NeoRx technology receives additional patent

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...